Mr Hamish Clouston
The Christie NHS Foundation Trust
Colorectal and Peritoneal Surgeon
Mr Clouston is a Colorectal and Peritoneal Surgeon in The Colorectal and Peritoneal Oncology Centre (CPOC) at The Christie NHS Foundation Trust. As a surgical oncologist in the CPOC he undertakes surgery for peritoneal pathology arising from tumours within the colon, rectum and appendix. This surgery includes Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. He also undertakes surgery for advanced colorectal malignancy including multivisceral rectal and colonic resections. As a core member of the anal cancer MDT he undertakes surgery for the early and recurrent anal cancers and the treatment of AIN. In his role as a core member of the neuroendocrine MDT he undertakes surgery for primary and metastatic neuroendocrine cancers.
Surgical Management of Advanced Colonic and Rectal Malignancies.
The Colorectal and Peritoneal Oncology Centre (CPOC) at The Christie NHS Foundation Trust provides a tertiary service for patients with advanced colorectal cancer in the Greater Manchester(GM) conurbation and is the GM designated single provider for advanced pelvic malignancies requiring multi-visceral exenterative resections. The seminar will focus on indications for surgery for advanced colorectal malignancy, surgical considerations and outcomes of the surgery.
EVEN MORE SEMINARS
Lucinda Billingham University of Birmingham - Cancer Research Clinical Trials Unit
National Lung Matrix Trial: testing multiple novel targeted treatments
Dr Andrew Jenks University Hospital Southampton NHS Foundation Trust
Rapid Access Multidisciplinary Palliative Assessment and Radiotherapy Treatment (RAMPART) clinic
Neil Oakley Sheffield Teaching Hospitals NHS Trust
Robotic Radical Prostatectomy for Prostate cancer aiming for Trifecta 2020
Anders Johnsson Scandinavian ChemoTech AB
Dynamic-ElectroEnhanced Chemotherapy brings relief to palliative patients with a large tumour burden
Dr. Catherine Zollman Penny Brohn UK
Integrative oncology: supporting whole person resilience and improving cancer outcomes